Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus—Learnings for Designing Novel Therapeutics
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At sublytic concentrations (~5 nM), PVL induces caspase-dependent apoptosis, while higher concentrations (~200 nM) provoke necrotic cell death via overwhelming pore formation [114,117,118].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Prevalence of Staphylococcus aureus Nasal Colonization in the United States, 2001–2002
Kuehnert, M. J., Kruszon‐Moran, D., Hill, H. A., McQuillan, G., McAllister, S. K., Fosheim, G., McDougal, L. K., Chaitram, J., Jensen, B., Fridkin, S. K., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/499632 · Cited by 659
Vandenesch, F., Lina, G., & Henry, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00012 · Cited by 405
Diep, B. A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T. R., Basuino, L., Mai, T. T., Marbach, H., Braughton, K. R., Whitney, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912403107 · Cited by 347
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J. (2013) · Nature · doi:10.1038/nature11724 · Cited by 291
DuMont, A. L., Yoong, P., Day, C. J., Alonzo, F., McDonald, W. H., Jennings, M. P., & Torres, V. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305121110 · Cited by 216
Reyes-Robles, T., Alonzo, F., Kozhaya, L., Lacy, D. B., Unutmaz, D., & Torres, V. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.005 · Cited by 179
Gravet, A., Colin, D. A., Keller, D., Giradot, R., Monteil, H., & Prévost, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01130-2 · Cited by 177
Spaan, A. N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E. A., Benito, Y., de Haas, C. J. C., Day, C. J., Jennings, M. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6438 · Cited by 166
Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
Research works printed but not linked: 55
- Adhikari RP, Kort T, Shulenin S, Kanipakala T, Ganjbaksh N, Roghmann MC, Holtsberg FW, Aman MJ (2015) Antibodies to S. aureus LukS-PV attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs. PLoS One 10:e0137874 · DOI
- Alonzo F 3rd, Torres VJ (2014) The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev 78:199–230 · DOI · Paper page
- Badarau A, Rouha H, Malafa S, Logan DT, Håkansson M, Stulik L, Dolezilkova I, Teubenbacher A, Gross K, Maierhofer B, Weber S, Jägerhofer M, Hoffman D, Nagy E (2015) Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH. J Biol Chem 290:142–156 · DOI
- Badarau A, Rouha H, Malafa S, Battles MB, Walker L, Nielson N, Dolezilkova I, Teubenbacher A, Banerjee S, Maierhofer B, Weber S, Stulik L, Logan DT, Welin M, Mirkina I, Pleban C, Zauner G, Gross K, Jägerhofer M, Magyarics Z, Nagy E (2016) Context matters: the importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. MAbs 8:1347–1360 · DOI
- Berube BJ, Bubeck Wardenburg J (2013) Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) 5:1140–1166 · DOI · Paper page
- Dal Peraro M, van der Goot FG (2016) Pore-forming toxins: ancient, but never really out of fashion. Nat Rev Microbiol 14:77–92 · DOI · Paper page
- Dalla Serra M, Coraiola M, Viero G, Comai M, Potrich C, Ferreras M, Baba-Moussa L, Colin DA, Menestrina G, Bhakdi S, Prévost G (2005) Staphylococcus aureus bicomponent gamma-hemolysins, HlgA, HlgB, and HlgC, can form mixed pores containing all components. J Chem Inf Model 45:1539–1545 · DOI
- Diep BA, Le VTM, Visram ZC, Rouha H, Stulik L, Dip EC, Nagy G, Nagy E (2016) Improved protection in a rabbit model of CA-MRSA necrotizing pneumonia upon neutralization of leukocidins in addition to alpha-hemolysin. Antimicrob Agents Chemother 60:6333–6340 · DOI
- Dong J, Qiu J, Zhang Y, Lu C, Dai X, Wang J, Li H, Wang X, Tan W, Luo M, Niu X, Deng X (2013) Oroxylin A Inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. In: Livesay DR (ed) PLoS Comput Biol 9:e1002869 · DOI
- Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A, Nagy E (2005) Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 12:387–398 · DOI · Paper page
- DuMont AL, Yoong P, Liu X, Day CJ, Chumbler NM, James DBA, Alonzo F, Bode NJ, Lacy DB, Jennings MP, Torres VJ (2014) Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect Immun 82:1268–1276 · DOI
- Fiaschi L, Di Paolo B, Scarselli M, Pozzi C, Tomaszewski K, Galletti B, Nardi-Dei V, Arcidiacono L, Mishra RP, Mori E, Pallaoro M, Falugi F, Torre A, Fontana MR, Soriani M, Bubeck Wardenburg J, Grandi G, Rappuoli R, Ferlenghi I, Bagnoli F (2016) Auto-assembling detoxified Staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin. In: Burns DL (ed) Clin Vaccine Immunol 23:442–450 · DOI
- Foletti D, Strop P, Shaughnessy L, Hasa-Moreno A, Casas MG, Russell M, Bee C, Wu S, Pham A, Zeng Z, Pons J, Rajpal A, Shelton D (2013) Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. J Mol Biol 425:1641–1654 · DOI
- Guillet V, Roblin P, Werner S, Coraiola M, Menestrina G, Monteil H, Prévost G, Mourey L (2004) Crystal structure of leucotoxin S component: new insight into the Staphylococcal beta-barrel pore-forming toxins. J Biol Chem 279:41028–41037 · DOI · Paper page
- Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, Keller A, O’Day T, Du Q, Cheng L, Damschroder M, Robbie G, Suzich J, Stover CK, Sellman BR (2014) Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 58:1108–1117 · DOI · Paper page
- Jayasinghe L, Bayley H (2005) The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis. Protein Sci 14:2550–2561 · DOI
- Joubert O, Viero G, Keller D, Martinez E, Colin DA, Monteil H, Mourey L, Dalla Serra M, Prévost G (2006) Engineered covalent leucotoxin heterodimers form functional pores: insights into S–F interactions. Biochem J 396:381–389 · doi:10.1042/bj20051878
- Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981–1003 · DOI · Paper page
- Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Warfield KL, Shulenin S, Aman MJ (2013) Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. PLoS One 8:e65384 · DOI
- Katsumi H, Tomita T, Kaneko J, Kamio Y (1999) Vitronectin and its fragments purified as serum inhibitors of Staphylococcus aureus gamma-hemolysin and leukocidin, and their specific binding to the hlg2 and the LukS components of the toxins. FEBS Lett 460:451–456 · DOI
- Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K (2001) Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225–1240 · DOI · Paper page
- Laventie BJ, Guérin F, Mourey L, Tawk MY, Jover E, Maveyraud L, Prévost G (2014) Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface. In: Diep BA (ed) PLoS ONE 9:e92094 · DOI
- Lewis M, Weaver CD, McClain MS (2010) Identification of small molecule inhibitors of Clostridium perfringens ε-toxin cytotoxicity using a cell-based high-throughput screen. Toxins (Basel) 2:1825–1847 · DOI
- Li H, Zhao X, Wang J, Dong Y, Meng S, Li R, Niu X, Deng X (2015) β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection. Sci Rep 5:17668 · doi:10.1038/srep17668
- Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132 · DOI · Paper page
- Löffler B, Hussain M, Grundmeier M, Brück M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA, Peters G (2010) Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. In: Cheung A (ed) PLoS Pathog 6:e1000715 · DOI · Paper page
- Malachowa N, Kobayashi SD, Braughton KR, Whitney AR, Parnell MJ, Gardner DJ, Deleo FR (2012) Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis 206:1185–1193 · DOI
- Menestrina G (1986) Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol 90:177–190 · DOI · Paper page
- Meyer F, Girardot R, Piemont Y, Prevost G, Colin DA (2009) Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding. Infect Immun 77:266–273 · DOI · Paper page
- Monma N, Nguyen VT, Kaneko J, Higuchi H, Kamio Y (2004) Essential residues, W177 and R198, of LukF for phosphatidylcholine-binding and pore-formation by staphylococcal -hemolysin on human erythrocyte membranes. J Biochem 136:427–431 · DOI
- Morinaga N, Kaihou Y, Noda M (2003) Purification, cloning and characterization of variant luke-lukd with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 47:81–90 · DOI · Paper page
- Nguyen VT, Kamio Y, Higuchi H (2003) Single-molecule imaging of cooperative assembly of γ-hemolysin on erythrocyte membranes. EMBO J 22:4968–4979 · DOI
- Nocadello S, Minasov G, Shuvalova L, Dubrovska I, Sabini E, Bagnoli F, Grandi G, Anderson WF (2016) Crystal structures of the components of the Staphylococcus aureus leukotoxin ED. Acta Cryst D Struct Biol 72:113–120 · DOI
- Oganesyan V, Peng L, Damschroder MM, Cheng L, Sadowska A, Tkaczyk C, Sellman BR, Wu H, Dall’Acqua WF (2014) Mechanisms of neutralization of a human anti-alpha toxin antibody. J Biol Chem 289:29874–29880 · DOI
- Olson R, Nariya H, Yokota K, Kamio Y, Gouaux E (1999) Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat Struct Biol 6:134–140 · DOI
- Pédelacq JD, Maveyraud L, Prévost G, Baba-Moussa L, González A, Courcelle E, Shepard W, Monteil H, Samama JP, Mourey L (1999) The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure 7:277–287 · DOI
- Potrich C, Bastiani H, Colin DA, Huck S, Prévost G, Dalla Serra M (2009) The influence of membrane lipids in Staphylococcus aureus gamma-hemolysins pore formation. J Membr Biol 227:13–24 · DOI
- Qiu J, Niu X, Dong J, Wang D, Wang J, Li H, Luo M, Li S, Feng H, Deng X (2012) Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of -hemolysin. J Infect Dis 206:292–301 · DOI
- Ramaro N, Sanchis V (2013) The pore-forming haemolysins of Bacillus cereus: a review. Toxins (Basel) 5:1119–1139 · DOI · Paper page
- Reyes-Robles T, Lubkin A, Alonzo F 3rd, Lacy DB, Torres VJ (2016) Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis. EMBO Rep 17:428–440 · DOI
- Roblin P, Guillet V, Joubert O, Keller D, Erard M, Maveyraud L, Prévost G, Mourey L (2008) A covalent S-F heterodimer of leucotoxin reveals molecular plasticity of beta-barrel pore-forming toxins. Proteins 71:485–496 · DOI
- Rouha H, Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M, Jägerhofer M, Maierhofer B, Teubenbacher A, Dolezilkova I, Gross K, Banerjee S, Zauner G, Malafa S, Zmajkovic J, Maier S, Mabry R, Krauland E, Wittrup KD, Gerngross TU, Nagy E (2015) Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 7:243–254 · DOI · Paper page
- Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859–1866 · DOI · Paper page
- Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJ, van Kessel KP, Vandenesch F, Lina G, van Strijp JA (2013) The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors. Cell Host Microbe 13:584–594 · DOI · Paper page
- Spaan AN, Surewaard BG, Nijland R, van Strijp JA (2014a) Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu Rev Microbiol 67:629–650 · DOI · Paper page
- Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA (2014c) Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and γ-hemolysin CB with human C5a receptors. J Immunol 195:1034–1043 · DOI
- Sugawara T, Yamashita D, Kato K, Peng Z, Ueda J, Kaneko J, Kamio Y, Tanaka Y, Yao M (2015) Structural basis for pore-forming mechanism of staphylococcal alpha-hemolysin. Toxicon 108:226–231 · doi:10.1016/j.toxicon.2015.09.033
- Tanaka Y, Hirano N, Kaneko J, Kamio Y, Yao M, Tanaka I (2011) 2-Methyl-2,4-pentanediol induces spontaneous assembly of staphylococcal α-hemolysin into heptameric pore structure. Protein Sci 20:448–456 · doi:10.1002/pro.579
- Tawk MY, Zimmermann-Meisse G, Bossu JL, Potrich C, Bourcier T, Dalla Serra M, Poulain B, Prévost G, Jover E (2015) Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca2+ mobilization by human neutrophils. Cell Microbiol 17:1241–1257 · DOI
- von Eiff C, Friedrich AW, Peters G, Becker K (2004) Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 49:157–162 · DOI · Paper page
- Wu Q, Guo Z (2010) Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin-type of pore-forming bacterial toxins. Med Res Rev 30:258–269 · doi:10.1002/med.20167
- Yamashita K, Kawai Y, Tanaka Y, Hirano N, Kaneko J, Tomita N, Ohta M, Kamio Y, Yao M, Tanaka I (2011) Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components. Proc Natl Acad Sci U S A 108:17314–17319 · DOI · Paper page
- Yamashita D, Sugawara T, Takeshita M, Kaneko J, Kamio Y, Tanaka I, Tanaka Y, Yao M (2014) Molecular basis of transmembrane beta-barrel formation of staphylococcal pore-forming toxins. Nat Commun 5:4897 · DOI
- Yokota K, Kamio Y (2000) Tyrosine 72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the Staphylococcal γ-Hemolysin to human erythrocytes. Biosci Biotechnol Biochem 64:2744–2747 · doi:10.1271/bbb.64.2744
- Yoong P, Torres VJ (2015) Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence. Nat Commun 6:8125 · DOI · Paper page
Cited by
Staphylococcus aureus host interactions and adaptation
Howden, B. P., Giulieri, S. G., Wong Fok Lung, T., Baines, S. L., Sharkey, L. K., Lee, J. Y. H., Hachani, A., Monk, I. R., & Stinear, T. P. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00852-y · Cited by 689
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Rello, J., van Engelen, T. S. R., Alp, E., Calandra, T., Cattoir, V., Kern, W. V., Netea, M. G., Nseir, S., Opal, S. M., van de Veerdonk, F. L., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.03.011 · Cited by 143
Metadata
- Authors
- Badarau, A., Trstenjak, N., & Nagy, E.
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer Singapore
- Published
- 2017
- Pages
- 15-35
- ISSN
- 0065-2598
- 2214-8019
- Cited by
- 20
- References
- 10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus—Learnings for Designing Novel Therapeutics. https://app.cochat.ai/papers/10.1007/5584_2016_200
- The paper
- Badarau, A., Trstenjak, N., & Nagy, E. (2017). Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus—Learnings for Designing Novel Therapeutics. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/5584_2016_200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.